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Systematic Identification of Plasmodium
Falciparum Sporozoite Membrane Protein
Interactions Reveals an Essential Role for the
p24 Complex in Host Infection
Julia Knöckel1,2, Kirsten Dundas1,2,‡, Annie S. P. Yang3,‡, Francis Galaway1,2,
Tom Metcalf2, Geert-Jan van Gemert3, Robert W. Sauerwein3, Julian C. Rayner2,
Oliver Billker2,4, and Gavin J. Wright1,2,5,*
Sporozoites are a motile form of malaria-causing Plas-
modium falciparum parasites that migrate from the site of
transmission in the dermis through the bloodstream to
invade hepatocytes. Sporozoites interact with many cells
within the host, but the molecular identity of these in-
teractions and their role in the pathology of malaria is
poorly understood. Parasite proteins that are secreted and
embedded within membranes are known to be important
for these interactions, but our understanding of how they
interact with each other to form functional complexes is
largely unknown. Here, we compile a library of recombi-
nant proteins representing the repertoire of cell surface
and secreted proteins from the P. falciparum sporozoite
and use an assay designed to detect extracellular in-
teractions to systematically identify complexes. We iden-
tify three protein complexes including an interaction
between two components of the p24 complex that is
involved in the trafficking of glycosylphosphatidylinositol-
anchored proteins through the secretory pathway. Plas-
modium parasites lacking either gene are strongly inhibi-
ted in the establishment of liver-stage infections. These
findings reveal an important role for the p24 complex in
malaria pathogenesis and show that the library of re-
combinant proteins represents a valuable resource to
investigate P. falciparum sporozoite biology.
Malaria is a deadly mosquito-borne infectious disease
caused by unicellular Plasmodium parasites and despite
intensive control efforts is still responsible for almost half a
million deaths annually (1). Critical to mosquito–human trans-
mission is the sporozoite: a motile stage that develops within
oocysts located on the midgut of infected mosquitoes before
invading the mosquito salivary glands and being transmitted
during a subsequent blood meal. Once deposited in the
dermis, sporozoites disperse in apparently random directions
before entering the circulation and eventually enter the liver
where they invade hepatocytes and continue their develop-
ment (2). Targeting the sporozoite is an attractive choice for
vaccine development because sporozoites are extracellular
and therefore directly exposed to the host humoral immune
system, this stage of the infection is asymptomatic, and spo-
rozoites are few in number since only tens to hundreds are
transmitted (3–5). Of importance, malaria vaccines based on
attenuated whole sporozoites, as well as a subunit vaccine
incorporating components of the major sporozoite surface
protein CSP, have been shown to be effective in human trials,
although protection was typically short-lived (6).
Proteins that are displayed on the surface of the parasite or
released from intracellular secretory organelles such as the
rhoptries and micronemes are considered good subunit vac-
cine targets because they are directly accessible to host an-
tibodies. The main functions of these proteins are likely to be
the subversion of the immune response or the interaction with
host molecules to regulate different stages of infection, for
example, to power parasite motility or bind specific receptors
that control the tropism of host cell invasion. Because the
blood stages of Plasmodium falciparum can be cultured
in vitro, we have a comparatively good understanding of which
parasite proteins are displayed on the surface of the merozoite
and how they interact to form functional complexes. For
example, the major merozoite surface protein MSP1 is found
in a protein complex with MSP7 and MSP6 (7, 8) and the
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secreted P41 protein is tethered to the surface of the mero-
zoite by the glycosylphosphatidylinositol (GPI)-anchored P12
protein (9). Parasite protein complexes that are known to be
essential for P. falciparum erythrocyte invasion include the
interactions between AMA1 and RON2 (10) and more recently
those proteins that directly bind RH5 including cysteine-rich
protective antigen (11), RH5 interacting protein (12), and
P113 (13). Mechanistically, vaccine-elicited antibodies that
target the components of these protein complexes on the
parasite surface may neutralize blood-stage parasites by
inhibiting their function or formation (14). In contrast to the
blood stages, however, relatively little is known about the
biochemical composition and organization of the sporozoite
surface, although genetic targeting has revealed that several
parasite surface proteins are required for normal sporozoite
development and infection. For example, circumsporozoite
protein (CSP) is required for the development of sporozoites in
the oocyst (15, 16), TRAP family proteins (TRAP and TLP) are
important for sporozoite motility and infection (17, 18), and
members of the 6-cys family (P36 and P52) are important for
host receptor usage in hepatocyte invasion (19). Although we
have a good cellular description of how the sporozoite in-
teracts with host cells (20), a molecular understanding of these
behaviors is incomplete and yet could represent important
new opportunities for pre-erythrocytic malaria vaccines.
Identification of interactions between membrane-embedded
proteins is challenging because membrane proteins are both
amphipathic, making them difficult to solubilize in solvents that
retain their native conformation, and because interactions be-
tween them can be highly transient; together, these features
make it difficult to confidently interpret data from commonly
used methods such as biochemical purifications using native
material (21). To address these issues, we have developed an
approach called AVEXIS (for AVidity-based EXtracellular Inter-
action Screening) (22), which, together with a library of func-
tionally active recombinant blood-stage Plasmodium proteins
(23, 24), has permitted the biochemical identification and
characterization of parasite protein complexes at the surface of
the merozoite including the RH5 complex (13). Here, we use
proteomic analyses of Plasmodium sporozoites to compile a
recombinant protein library representing the cell surface re-
ceptor repertoire and secretome of the P. falciparum sporo-
zoite. We use this protein library and the AVEXIS approach to
identify interactions between sporozoite proteins and charac-
terize their role in the pathogenesis of Plasmodium infections.
EXPERIMENTAL PROCEDURES
Ethics Statement
Experiments involving animals were performed under UK Home
Office governmental regulations (project license numbers PD3DA8D1F
and P98FFE489) and European directive 2010/63/EU. Research was
approved by the Sanger Institute Animal Welfare and Ethical Review
Board.
Design of the Plasmodium Sporozoite Protein Library
To obtain a catalog of proteins that are expressed by sporozoites,
published proteomic data using mass spectrometry–based profiling of
midgut and salivary gland sporozoites (25–27) were combined to
create a list of unique proteins and protein expression constructs
designed essentially as described (23); we additionally included
several proteins expressed by ookinetes. Briefly, cell surface and
secreted proteins were initially identified by the presence of a signal
peptide and/or transmembrane domains using SignalP v4.0 (28) and
TMHMM v2.0 (29) software. To define the ectodomain regions, signal
sequences and transmembrane domains were removed and all po-
tential N-linked glycosylation sites (N-X-S/T, where X is not proline)
were systematically mutated by substituting the serine/threonine for
alanine to prevent inappropriate glycosylation when expressed in
mammalian cells. Sequences encoding the sporozoite protein ecto-
domains were codon optimized for expression in human cells and
made by gene synthesis (GeneART). Four genes failed synthesis and
three could not be subcloned into the mammalian expression plas-
mids, suggesting the insert was toxic in Escherichia coli (Table S1). All
sequences were flanked with unique 5′ NotI and 3′ AscI restriction
enzyme sites to allow inframe cloning in the bait and prey plasmids
(30). Both expression plasmids contain a highly efficient mouse vari-
able κ light chain signal peptide and a rat Cd4d3+4 epitope tag fol-
lowed by either a peptide sequence allowing biotinylation and 6-his
tag (baits) or pentamerizing COMP sequences followed by the beta-
lactamase enzyme and a 6-his tag (preys) (31). The same process
was followed for the Plasmodium berghei orthologs. All plasmids have
been deposited in the Addgene plasmid repository (www.addgene.
org/express).
Production of the Recombinant Bait and Prey Proteins
All proteins were produced recombinantly as a monobiotinylated
bait and a pentamerized prey by transient transfection of HEK293E
(32) or HEK293-6E cells (33) essentially as described (30). All proteins
were purified from the cell culture supernatant up to 6 days after
transfection using Ni2+-NTA resin either using automated purification
systems (GE Healthcare) or manually using Ni-NTA Agarose (Jena
Biosciences) and dialyzed extensively against Hepes-buffered saline
(HBS) or PBS.
Normalization of Bait and Prey Proteins
The expression levels of biotinylated bait and β-lactamase-tagged
prey proteins were quantified essentially as described (30). Briefly, for
bait proteins, serial dilutions of the purified, dialyzed proteins were
added to individual wells of a streptavidin-coated microtiter plate
(NUNC). Proteins were captured and washed with HBS-T (HBS/0.1%
Tween 20) followed by addition of 1 μg/ml mouse anti-rat Cd4 OX68
monoclonal antibody in HBS/0.2% bovine serum albumin (BSA) and
washed with HBS-T. Proteins were detected by addition of a goat-
anti-mouse alkaline-phosphatase conjugated antibody (Sigma
A4656), washing followed by addition of 1 mg/ml alkaline phosphatase
substrate 104 dissolved in diethanolamine buffer, and reading the
absorbance at 405 nm in an automated plate reader (FluoStar Optima,
BMG Labtech). For subsequent assays, the highest protein dilution
that saturated the biotin binding capacity of the well was used. The
activity of prey proteins was normalized by quantifying the activity of
the β-lactamase enzyme in the prey protein tag. Serial dilutions were
prepared in a 96-well flat bottom microtiter plate, and 20 μl was added
to 60 μl of a 242 μM solution of the colorimetric β-lactamase substrate
nitrocefin (Cayman Chemical Company). The kinetics of substrate
hydrolysis were followed for 20 min and prey proteins normalized to an
activity of ~2 nmol min−1 for use in subsequent assays. To produce
tetrameric preys to detect the CelTOS-PF3D7_0721100 interaction, a
P. Falciparum Sporozoite Membrane Protein Interactions
2 Mol Cell Proteomics (2021) 20 100038
dilution series of monomeric biotinylated protein (similar to bait
normalization) was incubated with 2 to 5 μg/ml alkaline phosphatase–
coupled streptavidin (Sigma) for 45 min to allow the formation of tet-
ramers and then used in an ELISA as described above. The lowest
dilution that did not give a signal at 405 nm was used for AVEXIS.
Western Blotting
Purified proteins were resolved by SDS-PAGE using Novex
NuPAGE 4% to 12% Bis Tris precast gels (Life Technologies). Pro-
teins were reduced by adding NuPAGE reducing agent to the sample
and antioxidant (Life Technologies) to the gel running buffer according
to the manufacturer's instructions. Proteins were blotted onto nitro-
cellulose membranes (Life Technologies) and protein-binding sites
blocked using a 2% BSA solution. Biotinylated proteins were detected
by incubating membranes with High-sensitivity Streptavidin–
horseradish peroxidase (HRP) (PIERCE), washing, and addition of
SuperSignal West Pico Chemiluminescent substrate (PIERCE) and
developed on photographic film.
Enzyme-Linked Immunosorbant Assay
ELISAs were performed by capturing biotinylated bait proteins into
individual wells of streptavidin-coated 384-well plates (Nunc). Plates
were washed for 30 min with 50 μl PBS-T (0.2% Tween) and blocked
with PBS-2% BSA for a minimum of 3 h A volume of 20 μl of a bait
protein diluted in PBS-2% BSA at a concentration previously deter-
mined as the amount required to saturate the biotin binding capacity
of the well was added in triplicate and incubated for at least 16 h at 4
◦C. Where required, a similar set of bait protein dilutions were heat
inactivated for 30 min at 70 ◦C. Antisera from pooled Malawian adults
(23) were centrifuged at 13,000 rpm for a minimum of 1 h, diluted in
PBS-2% BSA and incubated with rocking for at least 16 h at 4 ◦C
before adding to the antigen-coated plates for 1 h. Plates were
washed 3× in PBS-T before addition of a 1:10,000 dilution of rabbit-
anti-human polyvalent IgG/A/M (Sigma I8010) in PBS-2% BSA for
1 h, and washed in PBS-T, followed by 1:10,000 dilution of goat anti-
rabbit Poly-HRP IgG/A/M (PIERCE) in PBS-2% BSA for 1 h. Plates
were washed in PBS-T, and the HRP substrate ABTS (KPL) was
added and absorption at 405 nm determined using an automated
plate reader (FluoStar Optima, BMG Labtech).
Avidity-Based Extracellular Protein Interaction Screening Assay
Systematic screening for protein interactions was performed
essentially as described (22, 34). Briefly, normalized bait proteins were
immobilized on streptavidin-coated 96-well microtiter plates (Nunc)
and activity-normalized prey proteins added to the arrayed bait pro-
teins and incubated at room temperature for 1 h. The plates were
washed twice in HBS-T (0.2% Tween 20) and once in HBS before 60 μl
of 125 μg/ml nitrocefin (Cayman Chemical Company) was added and
the absorbance measured at 485 nm in a plate reader. When tetra-
merized preys were used, 1 mg/ml phosphatase substrate 104 in
diethanolamine buffer was added and the absorbance measured at
405 nm. The rat Cd200–Cd200R interaction was used as a positive
control, and a biotinylated Ox68 antibody that recognizes the Cd4-tag
in the prey was used as a prey capture control. Some bait and prey
proteins showed low levels of promiscuous binding in the screen (e.g.,
bait 56 and prey 27) but because of their lack of specificity and weak
binding signals were not investigated further.
Experimental Design and Statistical Rationale
The goal of the protein interaction screening was to identify directly
interacting proteins within the library of recombinant P. falciparum
sporozoite membrane proteins. Sixty-four bait proteins were tested for
interactions against 54 prey proteins; however, there were insufficient
amounts of one of the baits (protein 53–SIAP-1) and therefore this bait
was tested against 35 prey proteins. In total, 3437 binding tests were
performed: 46 proteins were present in both prey and bait libraries and
therefore tested in both bait–prey orientations; the other proteins were
consequently tested in one orientation, making a total of 2379 unique
interactions tested. The initial screen was performed once, but the
identified interactions were repeated in triplicate and further charac-
terized using surface plasmon resonance. Control baits and preys
were present in all experiments; typically the rat Cd200–CD200R
interaction is used as a positive control. Data are shown as mean
absorbance readings with standard deviations to show reproducibility
between replicates.
Surface Plasmon Resonance
A Biacore 8K instrument (GE Healthcare) was used for the surface
plasmon resonance studies essentially as described (35). In brief,
biotinylated bait proteins were immobilized on a streptavidin-coated
sensor chip (GE Healthcare). Approximately 400 RUs of the control
bait (biotinylated rat Cd4d3+4) were immobilized in the flow cell used
as a reference and the approximate molar equivalents of the query
protein immobilized in the other flow cells. Purified analyte proteins
were resolved by size exclusion chromatography on a Superdex 200
Increase 10/300 column (GE Healthcare) in HBS-P (10 mM Hepes,
150 mM NaCl, 0.05% v/v P20 surfactant) immediately before use in
surface plasmon resonance (SPR) experiments thereby removing any
aggregated protein that might influence kinetic measurements. The
surface was regenerated with a pulse of 2 M NaCl at the end of each
cycle, and all experiments were performed at 37 ◦C. Duplicate in-
jections of the same concentration in each experiment were super-
imposable demonstrating no loss of activity after regenerating the
surface. Binding data were analyzed in the manufacturer's Biacore 8K
evaluation software version 1.1 (GE Healthcare).
Cloning and Expression of P. berghei Orthologs
The P. berghei orthologs of the six identified interacting
P. falciparum proteins were identified using PlasmoDB (36). Se-
quences were modified in the same way as described in Design of the
Plasmodium Sporozoite Protein Library and the genes synthesized by
GeneART. The synthetic plasmids were digested with NotI and AscI
restriction enzymes (NEB) and were each subcloned into the bait and
prey vectors. Recombinant proteins were produced by transient
transfection of HEK293-E or 6E cells as described above.
P. berghei Genetic Targeting
P. berghei targeting plasmids for PIESP15 (PBANKA_0209200,
PbGEM-268595) and PBANKA_0800600, PbGEM-331155 were
obtained from the PlasmoGEM vector resource (plasmogem.sanger.
ac.uk) (37). To make targeting plasmids that disrupt the
PBANKA_0522500 and PBANKA_1241700 loci, oligonucleotides
were designed to amplify 5′ and 3′ homology regions of each gene.
Each homology arm was approximately 1 kbp long and spans the 5′
UTR into the open reading frame, and from inside the open reading
frame into the 3′UTR of each gene, respectively. Restriction sites were
added to the primer sequence to enable cloning of the PCR products.
PCRs were performed using Kapa HiFi HotStart Ready Mix (Kapa
Biosciences), and genomic DNA isolated from P. berghei GFP-LUC
parasites (38) was used as a template. PCR conditions were 5 min
at 95 ◦C followed by 35 cycles of 95 ◦C for 30 s, 55 ◦C for 30 s and 68
◦C for 1 to 3.5 min, and a final extension of 10 min at 68 ◦C. PCR
products were sequentially cloned into the KpnI and XmaI or the XhoI
and SacII restriction sites of the pR6K attL1-3xHA-hDHFR-yfcu-attL2
plasmid backbone (39) and used to transfect P. berghei parasites.
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Transfection and Cloning by Limiting Dilution
Recombinant parasites were generated by transfecting a parental
“wildtype” transgenic P. berghei strain expressing green fluorescent
protein (GFP) and luciferase (38). Transfections were done essentially
as described (40). Briefly, 6- to 12-week-old Balb/C or Theiler's orig-
inal mice were used for routine propagation of the parasites. Prior to
transfection, 10 μl DNA was digested with NotI restriction enzyme
(NEB) overnight at 37 ◦C to release the transfection cassette from the
plasmid backbone. DNA was purified by ethanol precipitation and
resuspended in 10 μl dH2O. Parasites were cultured in vitro for 20 to
22 h to obtain synchronized schizonts. Schizonts were purified using a
55% Nycodenz (Sigma)/PBS gradient and washed once in RPMI1640
medium. Pelleted schizonts were resuspended in P3 Primary cell
Nucleofector (Lonza, 18 μl/transfection), and 25 μl of this mix was
added to 5 μl of digested DNA. Twenty microliters of the mix was then
added to an individual well of a 16-well Nucleocuvette Strip and
pulsed using the AMAXA 4D-Nucleofector electroporator, program FI-
115. Parasites were immediately resuspended in 100 μl incomplete
RPMI1640 medium and injected into the tail vein of Balb/c mice. On
the following day in the morning, pyrimethamine (0.07 mg/ml, pH 4.5)
was added to the drinking water for parasite selection. Blood smears
were taken from day 7 after transfection to monitor parasitemia, and
when parasitemia reached 0.5% to 1%, blood was collected for
stocks and genotyping. Subsequently, a drop of blood was taken from
a mouse infected with the transfected parasites and parasites were
cloned by limiting dilution. Clonality (absence of the WT locus) was
confirmed by genotyping, and cloned parasites were then used for
experiments.
Genotyping of P. berghei Parasites for Validation of Gene
Disruption
To confirm integration of the transfection cassette into the genome
of the parasite, we designed specific oligonucleotides for each target
gene, annealing to the chromosome just outside the homology arm of
the plasmid (primer GT). This was paired with a universal primer that
anneals to the yfcu cassette in the targeting plasmid (primer GW2a or
b). To detect absence or presence of the WT locus, a gene-specific
primer located inside the gene sequence of the target gene (primer
QCR1) was paired with a reverse primer in the homology arm (QCR2).
Primers GW2 and QCR2 were then combined to detect the trans-
fection plasmid, which could be either integrated or not integrated in
the genome. Because the product size for the primer combination
PbPIESP15-GW2+GT was too large, two PCR reactions were done to
amplify one half of the fragment each. Therefore, primer GW2b was
combined with primer PIESP15-rev2 and primer GT was combined
with primer PbPIESP15-fwd2. Sequences for primers QCR1, QCR2,
and GT for PbANKA_0800600 and PbPIESP15were obtained from the
PlasmoGEM web page. All primer sequences are listed in Table S2.
PCR reactions were performed using Kapa HiFi HotStart Ready Mix
(Kapa Biosciences), and cycling conditions were 5 min at 95 ◦C fol-
lowed by 35 cycles of 95 ◦C for 30 s, 55 ◦C for 30 s, and 68 ◦C for 1 to
3.5 min and a final extension of 10 min at 68 ◦C. Samples were
separated on a 0.8% Agarose gel using Hyperladder 1kb (Bioline) as a
size standard.
In Vivo Phenotyping of Transgenic P. berghei Parasites
Anopheles stephensi mosquitoes were allowed to feed on anaes-
thetized P. berghei-infected Balb/C mice for no more than 15 min and
placed in an incubator at 19 ◦C thereafter. Nine to 11 days after
infection, mosquitoes were anesthetized and kept on ice and midguts
were dissected in PBS. Only mosquitoes with developed eggs were
dissected to ensure mosquitoes had taken a blood meal at the time of
feeding. Images were taken by fluorescence microscopy and used to
quantify GFP-positive oocysts. Oocysts were counted manually using
the cell counter plugin in ImageJ 1.45s software. To quantify the
number of sporozoites in salivary glands, mosquitoes were anes-
thetized 21 days after infection and salivary glands dissected in PBS.
Salivary gland sporozoites from 15 to 20 mosquitoes were released by
homogenizing the glands with a micropestle, and salivary gland debris
were pelleted by centrifugation for 5 min at 100g. Sporozoites were
subsequently counted in a hemocytometer. Groups of four mice were
infected by intravenous injection of 5000 salivary gland sporozoites
per mouse and the development of the parasites was followed in the
whole animal every 24 h for 72 to 96 h by an in vivo imaging system
(IVIS) imaging. For imaging, mice were injected with 200 μl D-luciferin
(30 mg/ml in Dulbecco's phosphate buffered saline, Source Bio-
sciences) and imaged under isoflurane anesthesia 10 min later using
an IVIS Spectrum Imaging System (Perkin Elmer).
Once parasites were observed in the blood by IVIS (usually 72 h
post sporozoite injection), thin blood smears were taken daily for a
minimum of 5 days and stained using Giemsa to monitor blood-stage
parasitemia. To determine parasitemia, at least 500 red blood cells
were counted and parasitemia was calculated as a percentage of
infected red blood cells per total number of red blood cells; percent-
ages were then used for growth curves.
Production of Polyclonal Antisera
For the production of polyclonal antisera, proteins were expressed
as nonbiotinylated monomers by transient transfection of
HEK293 cells, purified using the C-terminal his tag, and dialyzed
against PBS. For immunization, 50 μg protein per animal was adju-
vanted in Alhydrogel (Invivogen) and delivered intraperitoneally into 6-
to 8-week-old female Balb/C mice. Two subsequent boosts were
given with 20 μg per animal at 2 and 4 weeks after the initial injection.
Sera were obtained 1 week after the final immunization boost by
cardiac bleed and centrifugation of the whole blood after clotting.
P. falciparum Cell Invasion Assays
HC-04 cells were routinely cultured in Dulbecco's Modified Eagle
Medium: Nutrient Mixture F-12 (DMEM-F12; ThermoFisher
Cat#31330038), supplemented with 10% heat-inactivated fetal bovine
serum and 1× Penicillin/Streptomycin. These cells were incubated at
37 ◦C under 5% CO2 and split using trypsin when 80% confluency
was reached. Twelve hours before the assay, 50,000 cells per well
were seeded in a collagen-coated 96-well flat-bottom plate (Corning
Cat# CLS3603-48EA). On the day of the experiment, salivary glands of
P. falciparum NF-135-infected mosquitoes were dissected in 1 ml
DMEM-F12 media and crushed using a glass pestle to liberate the
sporozoites. Sporozoite numbers were determined using a hemocy-
tometer. Media from each of the hepatocyte-seeded wells were
removed and replaced with media containing 50,000 sporozoites per
well. The plate was centrifuged at 3000 rpm for 10 min and incubated
at 37 ◦C under 5% CO2 for 3 h. After 3 h, the supernatant was
removed and each well rinsed three times with PBS and trypsinized for
5 min to obtain single-cell suspension. The trypsinized sample was
neutralized in equal volumes of PBS supplemented with 10% FCS and
transferred to a 96-well V-bottom plate (Costar Cat#3897). Samples
were spun down at 1700 rpm for 4 min. Supernatants were removed,
and pellets were resuspended in fixation reagent as per manufac-
turer's instructions (eBioscience Foxp3/Transcription factor staining
buffer set; ThermoFisher Cat# 00-5523-00) and incubated at 4 ◦C for
30 min. Permeabilization buffer was added to each well after the in-
cubation, and the samples were pelleted at 1700 rpm for 4 min. The
supernatant was removed, the pellet was resuspended in per-
meabilization buffer containing 3SP2 (antibody against PfCSP 1:400
dilution) conjugated to FITC and incubated at 4 ◦C for 30 min. Per-
meabilization buffer was added to each well after the incubation, and
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the samples were pelleted at 1700 rpm for 4 min. The supernatant was
removed, and the pellets were resuspended in 1% paraformaldehyde
in PBS. Each sample was read by fluorescent activated cytometry
sorting to determine the percentage of FITC-positive (infected) cells.
Immunostaining of P. berghei Sporozoites
To determine the amount and subcellular localization of CSP, sali-
vary gland sporozoites were dissected from infected A. stephensi
mosquitoes 21 to 30 days after blood feeding on P. berghei-infected
mice. Sporozoites were isolated by homogenizing the glands with a
micropestle and centrifugation for 5 min at 100g to pellet salivary
gland debris. Sporozoites were subsequently counted in a hemocy-
tometer, and 10,000 sporozoites each were placed onto round 13-mm
coverslips and air dried. Coverslips were then stored at −80 ◦C with
dessicant until used for immunostaining. For immunostaining, the
coverslips were left to reach room temperature before being removed
from the bag containing desiccant. Coverslips were then placed into
individual wells of a 24-well plate (Nunc), and parasites were fixed with
a 4% formalin solution in PBS for 10 min on ice. After washing twice in
PBS, the coverslips were incubated with 0.1% Triton in PBS on ice for
15 min to permeabilize the parasites. All slides were washed twice in
PBS, 1% BSA (Sigma) and incubated with anti-CSP monoclonal
antibody, 1:1000 in PBS, 1% BSA for 1 h at room temperature. After
washing three times in PBS, 1% BSA parasites were incubated with
Cy3 goat anti-mouse IgG (Life Technologies A10521), 1:500 in PBS,
1% BSA for 30 min at room temperature, protected from light. Cov-
erslips were subsequently washed in PBS, 1% BSA and mounted on
microscope slides with Vectashield HardSet containing DAPI
(Vectorlabs).
RESULTS
A Library of P. falciparum Sporozoite Surface and Secreted
Proteins
To create a recombinant protein library representing the cell
surface receptor repertoire and secretome of the P. falciparum
sporozoite, we analyzed published proteome and tran-
scriptome datasets from both P. falciparum and Plasmodium
yoelii sporozoites (25, 26, 41). To identify proteins that are
likely to be displayed on the surface of the sporozoite or
secreted, we selected those that contain a predicted N-ter-
minal signal peptide and/or transmembrane domain using a
set of bioinformatic tools. The resulting list of 102 proteins
included 57 proteins that contained one or more
transmembrane-spanning regions, 11 that encoded a C-ter-
minal hydrophobic sequence for the addition of a GPI lipid
anchor, and 34 that had no obvious way of being tethered to a
membrane, and so were predicted to be secreted (Table S1).
Of these 102 proteins, 25 are also known to be expressed on
the blood stages (such as P38, RhopH3, and MSP1) and
already represented within our library of previously published
merozoite proteins (23, 24). For the remaining 77 proteins, we
designed expression constructs in a similar manner by trun-
cating the proteins just prior to the predicted transmembrane
region or GPI-anchor and using gene synthesis to codon
optimize the coding regions for expression in human cells (23).
Of these, 69 genes could be successfully synthesized and
subcloned into the mammalian expression plasmid (Table S1)
and were subsequently expressed as Cd4d3+4-tagged
enzymatically monobiotinylated bait proteins by transient
transfection of suspension-grown HEK293 cells. Using this
approach, 58 of the 69 proteins (84.1%) could be detected
after his-tag purification from the spent cell culture medium by
ELISA. As is typical for this approach, for those proteins that
were detectably expressed, levels varied widely across several
orders of magnitude but could be as high as ~50 μg/ml for
proteins such as TRAP and CSP. Forty-eight proteins could
be produced in sufficient quantities to be used in the subse-
quent experiments and were resolved by SDS-PAGE and
detected by anti-biotin Western blotting to determine their
integrity (Fig. 1). With the exception of three proteins, PSOP7,
B9, and PF3D7_0624400, whose major species was smaller
than expected, the proteins were expressed at the expected
mass, although some proteins did show evidence of being
processed. Those proteins that could not be detected or were
expressed at very low levels included proteins that localize to
the rhoptries (RALP1, ARNP, and MAEBL), both the LCCL-
domain containing secreted proteins LAP2 and LAP4, two
members of the TRAP family (CTRP and TREP), and two
members of the 6-cys family that are also expressed on
gametes (P47 and P48/45). We have previously observed that
proteins localized to the rhoptries of merozoites are also
poorly expressed in this system suggesting that a rhoptry-
specific chaperone may be required for expression using
this approach (23).
The Recombinant Sporozoite Proteins Are Immunoreactive
and Contain Conformational Epitopes
To systematically evaluate which of the recombinant pro-
teins within the sporozoite library contained conformational
epitopes, we quantified the immunoreactivity to purified im-
munoglobulins pooled from adult donors living in a
P. falciparum malaria-endemic region. Over half (35/60, 58%)
of the proteins were recognized by the pooled immune serum
(Fig. 2). We found that the overall immunoreactivity to sporo-
zoite antigens was lower than for merozoite antigens (23), as
expected given that the immune system is exposed to many
orders of magnitude fewer sporozoites than merozoites during
an infection. The most immunoreactive proteins were those
whose expression is not restricted to the sporozoite stage but
that are also expressed during the blood stages. Sporozoite
proteins that are not expressed by the blood stages generally
exhibited a lower immunoreactivity with CSP, PIESP15,
ETRAMP8, and three conserved proteins with unknown
function: PF3D7_0702900, PF3D7_0713700, and
PF3D7_0505700 being the most immunodominant. Except for
CSP, the immunoreactivity of the immune serum to heat-
treated proteins was either completely lost or reduced
compared with the untreated proteins, demonstrating that the
immune serum recognized conformational epitopes and sug-
gesting that most proteins were folded (Fig. 2). The lack of
heat-labile epitopes in recombinant CSP is consistent with the
known immunodominance of the repetitive “NANP” repeats,
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which are predicted to be natively unstructured (42). These
data demonstrate that the majority of soluble recombinant
P. falciparum sporozoite proteins expressed in mammalian
cells contain conformational epitopes and represent a valu-
able resource for studying the molecular pathology of
P. falciparum infections.
Identification of P. falciparum Sporozoite Surface Protein
Complexes by Systematic Protein Interaction Screening
To identify P. falciparum sporozoite extracellular protein
complexes we used the AVEXIS assay, which detects direct
interactions between soluble recombinant ectodomains
expressed as biotinylated bait and highly avid enzyme-tagged
prey proteins (22). To produce the sporozoite library as prey
proteins, the ectodomains were subcloned into a plasmid
containing tags for pentamer formation and expressed in
HEK293 cells. As expected, the levels of activity varied and 54
prey proteins were expressed at sufficient levels after their
activities had been normalized to the threshold level required
for the AVEXIS assay (Table S1). In total, 64 bait proteins were
systematically tested for interactions against the 54 prey
proteins (Fig. 3A). One of the baits (SIAP-1 - protein 53) was
expressed at low levels and therefore tested against just 35
prey proteins so that a total of 3437 binding tests were per-
formed. Forty-six of the proteins were present in both bait and
prey libraries and consequently tested in both bait–prey ori-
entations; the remaining proteins were therefore tested in a
single orientation only, resulting in a total of 2379 unique in-
teractions tested. We identified three interactions: the first
between a type I cell surface protein called PIESP15 and a
secreted protein: PF3D7_0702900, a second between two
members of the p24 family of proteins (PF3D7_0422100 and
FIG. 1. A library of recombinant P. falciparum sporozoite cell surface and secreted proteins. The library of sporozoite receptor ecto-
domains was expressed as soluble recombinant enzymatically biotinylated proteins in HEK293 cells, and the purified proteins were resolved by
SDS-PAGE under reducing conditions. Proteins were blotted and detected using streptavidin–horseradish peroxidase.
FIG. 2. The recombinant P. falciparum sporozoite proteins contain heat-labile conformational epitopes. The immunoreactivity of the
recombinant sporozoite proteins to immune serum was quantified by ELISA. Biotinylated proteins were normalized and captured on a
streptavidin-coated microtiter plate and probed with pooled immune sera from Malawian adults (blue). Reduced response of immune serum to
heat-treated (70 ◦C for 30 min) proteins (pink) demonstrates the presence of heat-labile conformational epitopes. Note that the 11 proteins
between MSP5 and P41 that are grouped on the right of the graph are additionally expressed in blood-stage parasites. Bar charts show means ±
SEM; n = 3. Positive immunoreactivity was defined as mean responses >3 SEM above the averaged control (dashed line).
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PF3D7_0526900), and the third between CelTOS and a pre-
dicted secreted protein (PF3D7_0721100). The PIESP15-
PF3D7_0702900 and p24 family interactions were identified
in both bait–prey orientations in the initial screen; however,
because the PF3D7_0721100 protein did not express at suf-
ficient levels in the prey format, the CelTOS-PF3D7_0721100
interaction was initially identified in one orientation. For
those five prey proteins that interacted with a specific bait, we
repeated the binding assays against all the baits in triplicate
and confirmed the interactions (Fig. 3B). The interaction be-
tween CelTOS and PF3D7_0721100 was confirmed using a
modified assay where monomeric biotinylated proteins were
clustered around an alkaline phosphatase–streptavidin con-
jugate to form avid tetrameric preys, which then could be used
to probe immobilized baits to test for interactions (43). Using
this method, we could show binding of CelTOS and
PF3D7_0721100 in both orientations relative to controls
(Fig. S1).
The Interactions Are Conserved Between Orthologous
Proteins in P. berghei
To further characterize these interactions, we first used SPR
to establish whether the proteins could directly interact and
quantify their biophysical binding parameters. For each inter-
acting pair, one protein was purified and serial dilutions
injected over its binding partner expressed as a biotinylated
protein and immobilized on a streptavidin-coated sensor chip.
Clear binding was observed for each interaction, and the
FIG. 3. Identification of three P. falciparum sporozoite complexes by systematic extracellular protein interaction screening. A, the
library of cell surface and secreted sporozoite proteins was expressed as biotinylated bait and enzyme-tagged pentameric prey proteins and
systematically screened for interactions using the AVEXIS assay. The results are presented as a quantitative binding grid. The biotinylated baits
(arranged vertically according to the numbers in Table S1) were immobilized in individual wells of streptavidin-coated microtiter plates and tested
for direct binary interactions with the same proteins expressed as pentameric β-lactamase-tagged preys (arranged horizontally). Binding by
specific baits is quantified by detecting the capture of prey proteins and hydrolysis of the colorimetric β-lactamase substrate nitrocefin. B, the
five named prey proteins that interacted with a bait were retested in triplicate against the arrayed baits and the interactions confirmed. Controls
were: positive (+) Cd200 bait -Cd200R prey; negative (−) Cd200 bait with corresponding sporozoite protein prey. Bars represent mean ± SD;
n = 3.
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association and dissociation binding parameters were quan-
tified by fitting the series of binding traces to a 1:1 binding
model (Fig. 4A). As expected, the two interactions involving a
protein predicted to be secreted exhibited slower dissocia-
tions than the membrane-tethered p24 complex proteins (21).
Genome analysis revealed that the six proteins forming
complexes had identifiable orthologs in the genomes of all
Plasmodium species sequenced to date (36). To determine if
the protein interactions were conserved across species, we
expressed the orthologs of these proteins from the rodent
parasite P. berghei as both baits and preys and tested if they
could directly interact using the AVEXIS assay. We could
detect robust interactions between PbPIESP15 and
PbANKA_0800600 and the two P. berghei p24 complex pro-
teins in both bait–prey orientations (Fig. 4, B and C). We were
unable to determine if the interaction between CelTOS and
PF3D7_0721100 was conserved between the P. berghei
orthologs of these proteins because repeated attempts to
produce the P. berghei ortholog of PF3D7_0721100 failed;
therefore, this interaction was not investigated further. These
data demonstrate evolutionary conservation of the interaction
interfaces, which is striking since the amino acid sequence
identity of the extracellular regions was relatively modest: 58%
and 64% for the two p24 complex proteins and 42% and 75%
FIG. 4. Biophysical characterization of the three sporozoite complex interactions and conservation of interactions with orthologous
proteins in P. berghei. A, biophysical characterization of the three P. falciparum sporozoite interactions by surface plasmon resonance. For
each interacting pair, one protein was immobilized on the sensor chip and twofold serial dilutions of the indicated corresponding binding partner
was injected to quantify binding parameters. The raw sensorgram data (black lines) were fitted to a 1:1 binding model (red lines) to derive the
association (ka) and dissociation (kd) rate constants. B, the entire ectodomains of the P. berghei orthologs of PIESP15 (PBANKA_0209200) and
PF3D7_0702900 (PBANKA_0800600), as well as PF3D7_0422100 (PBANKA_0522500) and PF3D7_0526900 (PBANKA_1241700) (C), were
expressed as both bait and prey proteins and shown to directly interact using the AVEXIS assay in both bait–prey orientations. The rat Cd200–
Cd200R interaction was used as a positive control (+ve); negative control bait (−ve) was Cd200. (D) The PIESP15–PBANKA_0800600 interaction
but not the control Cd200–Cd200R interaction was inhibited in a dose-dependent manner by addition of EDTA as detected by AVEXIS. Bars and
data points indicate means ± SD; n = 3.
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for PIESP15 and PF3D7_0702900, respectively. We next
sought to characterize the biochemical interaction between
PIESP15 and PF3D7_0702900 in more detail. Both proteins
contain recognizable protein domains in their extracellular
regions: PIESP15 has an L-type lectin domain, so named
because it has homologies to lectins found in leguminous
plants (44), and PF3D7_0702900 contains tandem EF-hand
domains. It seemed unlikely that the PIESP15–
PF3D7_0702900 interaction involved carbohydrate binding
because Plasmodium parasites lack the glycosyltransferase
enzymes necessary for complex carbohydrate modifications
(45, 46), and because of the design of the recombinant pro-
teins the only predicted glycosylation was present within the
Cd4 protein tag common to all bait proteins. Both L-type lectin
and EF hand domains are known to require calcium ion co-
factors in their binding sites (47, 48), and consistent with this
we observed that the PIESP15- PF3D7_0702900 interaction
was inhibited in a dose-dependent manner in the presence of
the divalent ion chelator, EDTA (Fig. 4D).
Both Genes Encoding p24 Complex Proteins Are Required
for P. berghei Liver-Stage Infection
The cross-species conservation of both the PIESP15-
PF3D7_0702900 and p24 complex protein interactions sug-
gested that P. berghei was a suitable and experimentally
tractable model and enabled us to further validate these in-
teractions by asking if parasites lacking genes encoding
interacting proteins had similar infection phenotypes. To make
gene-deficient parasites for all four genes, we used existing
plasmids from the PlasmoGEM resource to target both
PbANKA_0800600 and PIESP15 (49). Gene targeting plas-
mids for the P. berghei orthologs of both p24 complex genes,
PBANKA_1241700 and PBANKA_0522500, were not avail-
able, so these were designed and constructed (Fig. S2). Gene-
deficient parasites for all four genes were made by electro-
porating erythrocytes infected with a GFP-luciferase-
transgenic “wildtype” P. berghei parental line and then
cloned by limiting dilution. Parasites were genotyped to
confirm recombination at the targeted locus (Figs. S2, B and C
and S3). Mosquitoes were infected with the cloned parasite
lines, and the infection was quantified throughout the life cycle
in both the mosquito vector and mammalian host. We
observed that both the ΔPbPIESP15 and ΔPbANKA_0800600
parasite lines had no overt infection phenotype in either the
mosquito or in mice compared with the wild-type parental line
(Fig. S4). This lack of infection phenotype was consistent with
the inability of polyclonal antibodies to both PIESP15 and
PF3D7_0702900 to prevent invasion of P. falciparum sporo-
zoites in human cells (Fig. S5). By contrast, P. berghei para-
sites lacking either PBANKA_1241700 or PBANKA_0522500
infected mosquitoes indistinguishably from the wildtype line
(Fig. 5, A and B), whereas intravenous infections of mice with
salivary gland sporozoites resulted in a striking reduction in
the number of parasites in the liver stage of infection for both
genes (Fig. 5, C and D). This was confirmed by a significant
delay in the appearance of parasites in the blood of infected
mice (Fig. 5E).
DISCUSSION
In this study we have compiled a library of soluble recom-
binant forms of the membrane-embedded and secreted pro-
teins from the P. falciparum sporozoite. We have shown how
this resource can be used to characterize the host humoral
immune response in patients with malaria and identify protein
complexes that are important for sporozoite function. A key
feature of this resource is that we have produced the proteins
in a mammalian expression system to increase the chances
that the proteins contain structurally critical posttranslational
modifications such as disulfide bonds and thereby adopt their
native conformation, which is essential for retaining extracel-
lular binding functions. A similar library representing the
secreted and membrane-embedded proteins from the
P. falciparum merozoite has proven very valuable to define the
serology of the infected host (50), identify both parasite–
parasite (9, 13) and host–parasite protein interactions
(51–54), as well as blood-stage vaccine candidate screening
(55). An important facet of this protein library is that many
antigens can be assessed in parallel so that they can be
directly compared in a systematic manner rather than the
more common testing of proteins individually, which in-
troduces technical variation that makes comparison very
difficult. We therefore envision that this resource will be an
important tool for the malaria community and have an impact
in defining a better molecular understanding of the basic
infection biology of the P. falciparum sporozoite; ultimately,
these findings will contribute toward providing new opportu-
nities for therapeutic interventions.
Of the three interactions we describe, the interaction be-
tween the p24 complex proteins PF3D7_0526900 and
PF3D7_0422100 was of particular interest because P. berghei
parasites lacking the orthologs of either of these genes
exhibited strong sporozoite in vivo infection phenotypes. p24
proteins contain a GOLD (GOLgi Dynamics) domain, and four
can be readily identified from their primary protein sequence in
Plasmodium spp. genomes. Most p24 family proteins are
ubiquitously expressed, although some may show elevated
expression in different developmental contexts, and at least
three are abundant in sporozoites and therefore represented in
our library. We only observed interactions between two of
these three proteins suggesting that there is binding speci-
ficity within the family, which is most likely mediated by the
regions of predicted coiled coil in the lumenal domain (56). p24
family proteins are mainly localized to the membranes of the
early secretory pathway, and experiments in yeast have sug-
gested that they play major roles as cargo receptors for GPI-
linked proteins. Their lumenal (ectodomain) regions function
as a lectin by binding the oligo-mannose glycans in the GPI
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anchor (57) while their short cytoplasmic tails nucleate the
formation of both COPI and COPII vesicle coats through their
dilysine and phenylalanine-containing motifs, respectively
(58). One likely molecular interpretation for the phenotypes of
sporozoites lacking the interacting p24 family proteins is that
they are unable to appropriately traffic GPI-anchored proteins
that are important for sporozoite invasion of host cells to the
sporozoite surface. One obvious candidate is CSP, but we did
FIG. 5. Both genes encoding the interacting p24 complex proteins are required for P. bergheimammalian host liver-stage infection. A,
the number of oocysts per midgut in A. stephensi mosquitoes infected with P. berghei ΔPBANKA_1241700 or ΔPBANKA_0522500 were
counted and found to be not significantly different from the GFP-luciferase transgenic wildtype parental strain. Data points are individual
midguts; median is indicated and statistical comparisons were performed using the Mann–Whitney test; p-values > 0.05 were considered
nonsignificant (ns). B, average number of salivary gland (SG) sporozoites per mosquito. About 15 to 20 mosquitoes were dissected, and
sporozoites isolated from the salivary glands were counted. The columns represent the average number of salivary gland sporozoites across
four independent experiments. Columns represent the mean with SD; statistical analysis was performed using an unpaired t test. C, P. berghei
ΔPBANKA_1241700 or ΔPBANKA_0522500 parasites do not establish robust liver-stage infections in mice compared with wildtype control.
Groups of four mice were infected by intravenous administration of 5000 isolated salivary gland sporozoites, and the resulting parasitemia was
quantified in the whole animal using luciferase-based bioluminescence using an in vivo imaging system. Data points are mean ± SD; n = 4. D,
normalized bioluminescence images collected on each day after infection; the left-most animal in each cohort is an uninfected control. E, the
prepatency period before detection of blood-stage parasitemia is significantly delayed in ΔPBANKA_1241700 and ΔPBANKA_0522500 par-
asites relative to the wildtype control. WT animals were culled on day 7 because they showed signs of disease (indicated with a cross). Asexual
blood-stage parasitemia was quantified by microscopic analysis of blood smears taken between 4 and 8 days after infection. Shown are the
results from one of two independent experiments with similar results. Data points are mean ± SD; n = 4. The prepatency period was less than
4 days for the parental line and 7.0 ± 0.7 (mean ± SD; n = 4) for ΔPBANKA_0522500 and 7 ± 1 for ΔPBANKA_1241700.
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not observe any obvious difference in the localization or
amount of CSP at the surface of sporozoites that lacked either
PBANKA_1241700 or PBANKA_0522500 (Fig. S6). It is known
that p24 family proteins are not essential for GPI-anchored
protein trafficking since an engineered yeast strain lacking
all known p24 family proteins only has a subtle phenotype that
affects the rate and fidelity of protein trafficking (59). This
suggests that most GPI-anchored proteins in yeast necessary
for laboratory growth can be trafficked by “bulk flow” through
the secretory pathway. Perhaps because CSP is so abundant
at the sporozoite surface, it mainly relies on bulk flow for
secretion and so is not affected by the loss of p24 family
proteins. The infection phenotype we observed may therefore
be due to mistrafficking of one or more of the several other
GPI-anchored proteins that are expressed by sporozoites.
Of the two other interactions that we identified, we were
able to show that P. berghei parasites genetically targeted for
genes encoding the interacting proteins PIESP15 and
PbANKA_800600 had no overt infection phenotypes, although
because sporozoites were delivered by intravenous injection,
there remains the formal possibility of a phenotype in sporo-
zoite behavior in the dermis. These findings are consistent
with the lack of in vivo blood-stage growth phenotypes for
knockouts of these genes in P. berghei as part of a large-scale
genetic screen (49), as well as a previous smaller-scale ge-
netic screen focused on identifying genes encoding cell sur-
face and secreted proteins required by the ookinete to infect
mosquitoes (60). There is proteomic evidence from several
studies that these proteins are not restricted to sporozoites in
P. falciparum but can be detected in other stages including
gametocytes (61) and blood stages (62). Of interest, insertional
mutagenesis genetic screens have shown that both PIESP15
and PF3D7_0702900 are very important for in vitro blood-
stage culture in P. falciparum providing evidence that these
genes may play important roles in P. falciparum in other life-
cycle stages (63). It is worth noting that the genes encoding
PF3D7_0702900/PbANKA_0800600 are currently annotated
as a “putative centrin” in gene databases, which appears to be
a computational prediction based on very low (<30%) protein
sequence identity. There is no functional evidence to support
this claim and both PF3D7_0702900/PbANKA_0800600 have
confident signal peptide predictions strongly suggesting an
extracellular localization, which would not be compatible with
the required cytoplasmic localizations of centrin and its known
role in centrosome biology. We were not able to further
investigate the functional role of the interaction between
CelTOS, a protein of considerable interest owing to its role in
mosquito infection and cell traversal (64), and
PF3D7_0721100 in P. berghei because initial attempts to
genetically target the P. berghei ortholog PBANKA_0618600
did not result in any recombinants and we were unable to
express the protein in a recombinant form.
In summary, we have produced a library of secreted and
membrane-embedded proteins that are expressed by the
P. falciparum sporozoite using a mammalian expression
system. We believe that these proteins will be particularly
useful to the malaria research community because of the
challenges in obtaining large amounts of sporozoite material
and solubilizing membrane-embedded proteins in their
native conformation. Given that targeting the sporozoite
stage either as attenuated whole sporozoites or as a
sporozoite surface protein-based subunit vaccine has
shown promise in malaria vaccine development (6), gaining a
greater understanding of these proteins and how they
function will not only advance a molecular understanding of
sporozoite infection biology but is also likely to provide
important information to improve sporozoite-based malaria
vaccine design.
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